2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Reboxetine: new trials by email Literature Review of Reboxetine trials Research Report on Reboxetine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects Citalopram 40mg, Reboxetine 8 mg, Placebo oral tablet - Stress Urinary Incontinence, Fecal Incontinence | Phase 1 | Completed | University Hospital Bispebjerg and Frederiksberg | 24 | 2019-09-17 | 2021-06-09 |
| Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK) MDMA, Reboxetine, 8 mg, Placebo - Mood Disorder, Substance-related Disorders | Phase 1 | Completed | University Hospital, Basel, Switzerland | 16 | 2009-04-01 | 2013-01-25 |
Amphetamine-Related Disorders (1) · Fecal Incontinence (1) · Mood Disorders (1) · Substance-Related Disorders (1) · Urinary Incontinence, Stress (1)
University Hospital Bispebjerg and Frederiksberg (1) · University Hospital, Basel, Switzerland (1)
Denmark (1) · Switzerland (1)
Jesper Sonne, DMSc (1) · Matthias E Liechti, MD (1)
PMID 22700038, PMID 29912955, PMID 39076155
2019 (1)